1. Home
  2. Detail

@mr.been923: #LIVEIncentiveProgram #LIVEFEST2026 #MakeLIVECount #paidpartnershipwithtiktok

mr' Been
mr' Been
Open In TikTok:
Region: US
Thursday 29 October 2026 18:54:32 GMT
41852
747
7
12

Music

Download

No Watermark .mp4 (0.96MB) No Watermark(HD) .mp4 (0.81MB) Watermark .mp4 (0.93MB) Music .mp3

Comments

user75309783505456
keller :
nice one
2026-10-29 22:09:04
0
user6147157684281
short-tempered :
nice
2026-10-29 19:14:24
1
hapsa.diagola
Hapsa Diagola :
😂😂😂
2026-10-29 19:32:18
1
adama.sawadogo5625
Adama Sawadogo :
😂😂😂
2026-10-29 19:18:27
1
eder.abdoul
ABDOUL JOM :
🥰🥰🥰
2026-10-29 19:11:17
1
unforgetablejourn
UNforgetableJourneys :
😳😳😳
2026-10-29 22:53:23
0
user58145369084335
Mariama Mendy 2025 :
🥰
2026-10-29 23:56:16
0
To see more videos from user @mr.been923, please go to the Tikwm homepage.

Other Videos

Tak jauh beza pun beli ngan buat
Tak jauh beza pun beli ngan buat


We talk a lot about reversing biological age. But how do we actually know when it's working? In this conversation with Dr. Vera Gorbunova and Dr. Andrei Seluanov, they break down one of the most important — and most overlooked — questions in longevity science. The tools being used to measure cellular aging, starting with methylation clocks and now expanding into multiomics biomarkers, represent some of the most significant breakthroughs in the field. But as Dr. Gorbunova and Dr. Seluanov are honest enough to point out: they're not perfect. Especially when it comes to assessing any one individual. It's a critical distinction. The science is advancing. The markers are getting more sophisticated. And yet the gap between what we can measure at a population level and what we can confidently say about a single person remains one of the field's biggest open questions. Progress and limitation, existing at the same time. Explore the full conversation, out now on all major streaming platforms.
We talk a lot about reversing biological age. But how do we actually know when it's working? In this conversation with Dr. Vera Gorbunova and Dr. Andrei Seluanov, they break down one of the most important — and most overlooked — questions in longevity science. The tools being used to measure cellular aging, starting with methylation clocks and now expanding into multiomics biomarkers, represent some of the most significant breakthroughs in the field. But as Dr. Gorbunova and Dr. Seluanov are honest enough to point out: they're not perfect. Especially when it comes to assessing any one individual. It's a critical distinction. The science is advancing. The markers are getting more sophisticated. And yet the gap between what we can measure at a population level and what we can confidently say about a single person remains one of the field's biggest open questions. Progress and limitation, existing at the same time. Explore the full conversation, out now on all major streaming platforms.


#explore #صدقة_جارية #قران
#explore #صدقة_جارية #قران
Buku Jutawan A.I #ai
Buku Jutawan A.I #ai

About

Legal